![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of EZH1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of EZH1 mRNA | CTD | PMID:15598610 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of EZH1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1305028 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EZH1 mRNA | CTD | PMID:32109520 | 2,4-dinitrotoluene | affects expression | ISO | RGD:1305028 | 6480464 | 2, 4-dinitrotoluene affects the expression of EZH1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1305028 | 6480464 | 2, 6-dinitrotoluene affects the expression of EZH1 mRNA | CTD | PMID:21346803 | antirheumatic drug | increases expression | ISO | RGD:1312813 | 6480464 | Antirheumatic Agents results in increased expression of EZH1 mRNA | CTD | PMID:24449571 | belinostat | increases expression | ISO | RGD:1312813 | 6480464 | belinostat results in increased expression of EZH1 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | decreases expression | ISO | RGD:1305028 | 6480464 | Benzo(a)pyrene results in decreased expression of EZH1 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | affects methylation | ISO | RGD:1312813 | 6480464 | Benzo(a)pyrene affects the methylation of EZH1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of EZH1 mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | ISO | RGD:1312813 | 6480464 | bisphenol A affects the expression of EZH1 mRNA | CTD | PMID:20170705 | bisphenol A | increases expression | ISO | RGD:1312813 | 6480464 | bisphenol A results in increased expression of EZH1 mRNA | CTD | PMID:29275510 | bisphenol A | affects expression | ISO | RGD:1305028 | 6480464 | bisphenol A affects the expression of EZH1 mRNA | CTD | PMID:25181051, PMID:30816183 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cisplatin | decreases expression | ISO | RGD:1312813 | 6480464 | Cisplatin results in decreased expression of EZH1 mRNA | CTD | PMID:27594783 | cisplatin | increases expression | ISO | RGD:1312813 | 6480464 | Cisplatin results in increased expression of EZH1 mRNA | CTD | PMID:27392435 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos, Crocidolite results in decreased expression of EZH1 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | RGD:1312813 | 6480464 | Cyclosporine results in increased expression of EZH1 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | RGD:1312813 | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA | CTD | PMID:26424790 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of EZH1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | RGD:1305028 | 6480464 | Dibutyl Phthalate results in increased expression of EZH1 mRNA | CTD | PMID:21266533 | disodium selenite | increases expression | ISO | RGD:1312813 | 6480464 | Sodium Selenite results in increased expression of EZH1 mRNA | CTD | PMID:18175754 | diuron | decreases expression | ISO | RGD:1305028 | 6480464 | Diuron results in decreased expression of EZH1 mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | ISO | RGD:1312813 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1312813 | 6480464 | Doxorubicin results in decreased expression of EZH1 mRNA | CTD | PMID:29803840 | ellagic acid | increases expression | ISO | RGD:1312813 | 6480464 | Ellagic Acid results in increased expression of EZH1 mRNA | CTD | PMID:12002526 | ethyl methanesulfonate | increases expression | ISO | RGD:1312813 | 6480464 | Ethyl Methanesulfonate results in increased expression of EZH1 mRNA | CTD | PMID:23649840 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of EZH1 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA | CTD | PMID:22206623 | glycerol 2-phosphate | multiple interactions | ISO | RGD:1312813 | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA | CTD | PMID:26424790 | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of EZH1 mRNA | CTD | PMID:20003209 | ketamine | increases expression | ISO | RGD:1305028 | 6480464 | Ketamine results in increased expression of EZH1 mRNA | CTD | PMID:20080153 | L-ascorbic acid | multiple interactions | ISO | RGD:1312813 | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA | CTD | PMID:26424790 | mercury atom | increases expression | ISO | RGD:1312813 | 6480464 | Mercury results in increased expression of EZH1 mRNA | CTD | PMID:16823088 | mercury(0) | increases expression | ISO | RGD:1312813 | 6480464 | Mercury results in increased expression of EZH1 mRNA | CTD | PMID:16823088 | methapyrilene | decreases expression | ISO | RGD:1305028 | 6480464 | Methapyrilene results in decreased expression of EZH1 mRNA | CTD | PMID:30467583 | monosodium L-glutamate | multiple interactions | EXP | | 6480464 | [Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of EZH1 mRNA | CTD | PMID:22078008 | nickel atom | decreases expression | ISO | RGD:1312813 | 6480464 | Nickel results in decreased expression of EZH1 mRNA | CTD | PMID:25583101 | nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of EZH1 mRNA | CTD | PMID:15878706 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EZH1 mRNA | CTD | PMID:34911549 | phenylmercury acetate | decreases expression | ISO | RGD:1312813 | 6480464 | Phenylmercuric Acetate results in decreased expression of EZH1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1312813 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA | CTD | PMID:27188386 | resveratrol | increases expression | ISO | RGD:1312813 | 6480464 | resveratrol results in increased expression of EZH1 mRNA | CTD | PMID:12002526 | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | EXP | | 6480464 | Buthionine Sulfoximine results in decreased expression of EZH1 mRNA | CTD | PMID:15878706 | SB 431542 | multiple interactions | ISO | RGD:1312813 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of EZH1 mRNA | CTD | PMID:35364107 | sodium arsenite | multiple interactions | EXP | | 6480464 | GSK-2816126 promotes the reaction [sodium arsenite results in increased expression of EZH1 mRNA] | CTD | PMID:35364107 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of EZH1 mRNA | CTD | PMID:17484886 | thioacetamide | increases expression | ISO | RGD:1305028 | 6480464 | Thioacetamide results in increased expression of EZH1 mRNA | CTD | PMID:23411599 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of EZH1 mRNA | CTD | PMID:29264374 | trichloroethene | increases methylation | ISO | RGD:1305028 | 6480464 | Trichloroethylene results in increased methylation of EZH1 gene | CTD | PMID:27618143 | trichostatin A | decreases expression | ISO | RGD:1312813 | 6480464 | trichostatin A results in decreased expression of EZH1 mRNA | CTD | PMID:24935251 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of EZH1 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | RGD:1312813 | 6480464 | Urethane results in decreased expression of EZH1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1312813 | 6480464 | Valproic Acid affects the expression of EZH1 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1312813 | 6480464 | Valproic Acid results in decreased expression of EZH1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1312813 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA | CTD | PMID:27188386 | vitamin E | increases expression | ISO | RGD:1312813 | 6480464 | Vitamin E results in increased expression of EZH1 mRNA | CTD | PMID:19244175 | |